B

Binex Co Ltd
KOSDAQ:053030

Watchlist Manager
Binex Co Ltd
KOSDAQ:053030
Watchlist
Price: 17 660 KRW -2.21%
Market Cap: 562.4B KRW
Have any thoughts about
Binex Co Ltd?
Write Note

Binex Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Binex Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Binex Co Ltd
KOSDAQ:053030
Cash & Cash Equivalents
â‚©6.5B
CAGR 3-Years
-43%
CAGR 5-Years
-17%
CAGR 10-Years
-6%
Yuhan Corp
KRX:000100
Cash & Cash Equivalents
â‚©279B
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
6%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash & Cash Equivalents
â‚©239.7B
CAGR 3-Years
59%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash & Cash Equivalents
â‚©47.9B
CAGR 3-Years
-35%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash & Cash Equivalents
â‚©102B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
11%
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash & Cash Equivalents
â‚©12.2B
CAGR 3-Years
-33%
CAGR 5-Years
5%
CAGR 10-Years
5%

See Also

What is Binex Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.5B KRW

Based on the financial report for Jun 30, 2024, Binex Co Ltd's Cash & Cash Equivalents amounts to 6.5B KRW.

What is Binex Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-6%

The average annual Cash & Cash Equivalents growth rates for Binex Co Ltd have been -43% over the past three years , -17% over the past five years , and -6% over the past ten years .

Back to Top